Is T2 Biosystems (TTOO) a risk you are willing to take?
What’s up with T2 Biosystems?
T2 Biosystems(TTOO) opened at $0.60, which means the stock is up 0.26% from yesterday’s closing price of 0.57. Today, the company has a high of $0.60 and a low of $0.56. The stock holds a market cap of $57.44 million which is not impressive since the P/E ratio is -0.44. The company has a 52-week high of $3.21 and a 52-week low of $0.24.
What is P/E ratio?
The price-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of a company’s share price to the company’s earnings per share. The ratio is used for valuing companies and to find out whether they are overvalued or undervalued. T2 Biosystems has a weak.A negative PE ratio means that a stock has negative earnings. In other words, the company was losing money in the past 12 months.
About T2 Biosystems
T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.